Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Deadline to Lead in Securities Fraud Lawsuit Against DENTSPLY SIRONA Inc. (XRAY) is January 27, 2025 - Contact Kaplan Fox & Kilsheimer LLP By: NewMediaWire December 11, 2024 at 09:00 AM EST NEW YORK - (NewMediaWire) - December 11, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. (“DENTSPLY” or the “Company”) (NASDAQ: XRAY) on behalf of investors that purchased or otherwise acquired DENTSPLY securities between December 1, 2022 and November 6, 2024 (the “Class Period”).CLICK HERE TO JOIN THE CASEIf you are an investor in DENTSPLY and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than January 27, 2025, to serve as a lead plaintiff for the purported class. If you have losses, we encourage you to contact us to learn more about the lead plaintiff process.On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products." The press release also states that “[t]he Company’s decision was made in consultation with the U.S. Food and Drug Administration (FDA)."Following this news, the price of DENTSPLY's stock fell $1.10 per share, or 4.5%, to close at $23.31 per share on October 25, 2024.Then, on November 6, 2024, in connection with reporting third quarter financial results, DENTSPLY issued a press release revising its 2024 outlook to reflect that organic sales are expected to be down 3.5% to 2.5% year-over-year compared to its prior outlook that organic sales would be down 1% to flat.Following this news, the price of DENTSPLY’s stock fell $6.72 per share, about 28%, to close at $17.26 per share on November 7, 2024.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this Notice, your rights, or your interests, please contact:CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Deadline to Lead in Securities Fraud Lawsuit Against DENTSPLY SIRONA Inc. (XRAY) is January 27, 2025 - Contact Kaplan Fox & Kilsheimer LLP By: NewMediaWire December 11, 2024 at 09:00 AM EST NEW YORK - (NewMediaWire) - December 11, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. (“DENTSPLY” or the “Company”) (NASDAQ: XRAY) on behalf of investors that purchased or otherwise acquired DENTSPLY securities between December 1, 2022 and November 6, 2024 (the “Class Period”).CLICK HERE TO JOIN THE CASEIf you are an investor in DENTSPLY and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than January 27, 2025, to serve as a lead plaintiff for the purported class. If you have losses, we encourage you to contact us to learn more about the lead plaintiff process.On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products." The press release also states that “[t]he Company’s decision was made in consultation with the U.S. Food and Drug Administration (FDA)."Following this news, the price of DENTSPLY's stock fell $1.10 per share, or 4.5%, to close at $23.31 per share on October 25, 2024.Then, on November 6, 2024, in connection with reporting third quarter financial results, DENTSPLY issued a press release revising its 2024 outlook to reflect that organic sales are expected to be down 3.5% to 2.5% year-over-year compared to its prior outlook that organic sales would be down 1% to flat.Following this news, the price of DENTSPLY’s stock fell $6.72 per share, about 28%, to close at $17.26 per share on November 7, 2024.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this Notice, your rights, or your interests, please contact:CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com
NEW YORK - (NewMediaWire) - December 11, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. (“DENTSPLY” or the “Company”) (NASDAQ: XRAY) on behalf of investors that purchased or otherwise acquired DENTSPLY securities between December 1, 2022 and November 6, 2024 (the “Class Period”).CLICK HERE TO JOIN THE CASEIf you are an investor in DENTSPLY and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than January 27, 2025, to serve as a lead plaintiff for the purported class. If you have losses, we encourage you to contact us to learn more about the lead plaintiff process.On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products." The press release also states that “[t]he Company’s decision was made in consultation with the U.S. Food and Drug Administration (FDA)."Following this news, the price of DENTSPLY's stock fell $1.10 per share, or 4.5%, to close at $23.31 per share on October 25, 2024.Then, on November 6, 2024, in connection with reporting third quarter financial results, DENTSPLY issued a press release revising its 2024 outlook to reflect that organic sales are expected to be down 3.5% to 2.5% year-over-year compared to its prior outlook that organic sales would be down 1% to flat.Following this news, the price of DENTSPLY’s stock fell $6.72 per share, about 28%, to close at $17.26 per share on November 7, 2024.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this Notice, your rights, or your interests, please contact:CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com
